AvalehtCGEN • NASDAQ
add
Compugen Ltd
Viimane sulgemishind
1,64 $
Tänane vahemik
1,67 $ - 2,06 $
Aasta vahemik
1,35 $ - 3,03 $
Turuväärtus
180,40 mln USD
Keskmine maht
512,30 tuh
P/E suhe
105,11
Dividendimäär
-
Põhibörs
NASDAQ
Uudised
Finantsandmed
Kasumiaruanne
Käive
Puhastulu
| (USD) | sept 2024info | Y/Y muutus |
|---|---|---|
Käive | 17,13 mln | — |
Põhitegevusega seonduv kulu | 9,04 mln | −14,99% |
Puhastulu | 1,28 mln | 112,95% |
Puhaskasumimarginaal | 7,45 | — |
Puhaskasum aktsia kohta | 0,01 | 109,09% |
EBITDA | 4,62 mln | 143,92% |
Tõhus maksumäär | 77,92% | — |
Bilansiaruanne
Kogu vara
Kõik kohustused
| (USD) | sept 2024info | Y/Y muutus |
|---|---|---|
Sularaha ja lühiajalised investeeringud | 112,71 mln | 95,99% |
Kogu vara | 123,52 mln | 82,69% |
Kõik kohustused | 63,03 mln | 338,18% |
Kogu omakapital | 60,49 mln | — |
Emiteeritud aktsiate arv | 89,54 mln | — |
Hinna ja väärtuse suhe P/B | 2,41 | — |
Varade tasuvus | 9,62% | — |
Kapitali tasuvus | 18,01% | — |
Rahavoog
Raha ja raha ekvivalentide muutus
| (USD) | sept 2024info | Y/Y muutus |
|---|---|---|
Puhastulu | 1,28 mln | 112,95% |
Põhitegevuse rahakäive | — | — |
Investeeringute raha | — | — |
Finantseerimise raha | — | — |
Raha ja raha ekvivalentide muutus | — | — |
Tasuta rahavoog | — | — |
Teave
Compugen Ltd. is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993. Compugen originally acted as service provider for pharma companies, supplying its software and computational services to predict different types of biological phenomena. It had arrangements with big companies such as Novartis AG, Abbot Laboratories and Pfizer Inc. Subsequently, Compugen made a decision to become a drug development company with its own internal pipeline, and in 2010, decided to a focus on oncology and immunology. OncoMed Pharmaceuticals and Five Prime Therapeutics are among Compugen's competitors. Wikipedia
Tegevjuht
Asutatud
10. veebr 1993
Veebisait
Töötajate arv
68
